<DOC>
	<DOCNO>NCT01360021</DOCNO>
	<brief_summary>This comparison efficacy Symbicort breath actuate dose inhaler Symbicort pressure meter dose inhaler 12 week twice day dose .</brief_summary>
	<brief_title>New Breath Actuated MDI Symbicort Compared Symbicort pMDI Budesonide pMDI 12 Weeks Twice Day</brief_title>
	<detailed_description />
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Male female 12 year Clinical diagnosis asthma accord American Thoracic Society definition least 6 month Prebronchodilator FEV1 ≥ 45 % ≤ 85 % predict normal Patients reversible airway obstruction Documented daily use inhale corticosteroid ≥ 3 month History lifethreatening asthma , define protocol asthma episode require intubation and/or associate hypercapnea , respiratory arrest hypoxic seizures 2 year prior Visit 2 Hospitalized previous 6 month asthma Required emergency treatment previous 6 month asthmarelated condition Intake oral , rectal parenteral glucocorticosteroid within 30 day enrolment Respiratory infection affect asthma within 30 day</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>